A Case-Oriented Therapeutic Approach Based on Evidence of Retinal Metabolic Demand in Juxtapapillary Capillary Hemangiomas as Part of von Hippel-Lindau Disease

Anna Friesacher; Christophe Valmaggia; Thomas Hundsberger; Margarita Todorova

doi:10.1055/a-1773-0155

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2022; 239(04): 548-551
DOI: 10.1055/a-1773-0155

Der interessante Fall

A Case-Oriented Therapeutic Approach Based on Evidence of Retinal Metabolic Demand in Juxtapapillary Capillary Hemangiomas as Part of von Hippel-Lindau Disease

Ein fallorientierter therapeutischer Ansatz basierend auf dem Nachweis des Stoffwechselbedarfs der Netzhaut bei juxtapapillären kapillären Hämangiomen im Rahmen der Von-Hippel-Lindau-Krankheit

Anna Friesacher

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Christophe Valmaggia

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Thomas Hundsberger

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Margarita Todorova

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

²Department of Ophthalmology, University of Basel, Basel, Switzerland

³Department of Ophthalmology, University of Zürich, Zürich, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Venkatesh P, Takkar B. Proposed Classification System for Retinal Capillary Angiomatosis. Ophthalmic Res 2019; 61: 115-119
2 Jesberg DO, Spencer WH, Hoyt WF. Incipient lesions of von Hippel-Lindau disease. Arch Ophthalmol 1968; 80: 632-640
3 Varshney N, Kebede AA, Owusu-Dapaah H. et al. A Review of Von Hippel-Lindau Syndrome. J Kidney Cancer VHL 2017; 4: 20-29
4 Lonser RR, Glenn GM, Walther M. et al. von Hippel-Lindau disease. Lancet 2003; 361: 2059-2067
5 Singh AD, Shields CL, Shields JA. Von Hippel-Lindau disease. Surv Ophthalmol 2001; 46: 117-142
6 Niemelä M, Lemeta S, Sainio M. et al. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Invest Ophthalmol Vis Sci 2000; 41: 1909-1915
7 Michels VV. Von Hippel-Lindau disease. In: Neuro-cutaneous diseases: a practical approach. Boston: Butterworth; 1987: 53-66
8 Choyke PL, Glenn GM, Walther MM. et al. Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995; 194: 629-642
9 Gaudric A, Krivosic V, Duguid G. et al. Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease. Ophthalmology 2011; 118: 142-149
10 Karimi S, Arabi A, Shahraki T. et al. Von Hippel-Lindau Disease and the Eye. J Ophthalmic Vis Res 2020; 15: 78-94
11 Schmid S, Gillessen S, Binet I. et al. Management of von Hippel-Lindau disease: an interdisciplinary review. Oncol Res Treat 2014; 37: 761-771
12 Wu P, Zhang N, Wang X. et al. Mosaicism in von Hippel-Lindau disease with severe renal manifestations. Clin Genet 2013; 84: 581-584
13 Sufan RI, Jewett MA, Ohh M. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol 2004; 287: F1-F6
14 Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674
15 Couly G, Coltey P, Eichmann A. et al. The angiogenic potentials of the cephalic mesoderm and the origin of brain and head blood vessels. Mech Dev 1995; 53: 97-112
16 Rojanaporn D, Kaliki S, Shields CL. et al. Morning glory disc anomaly with peripheral retinal nonperfusion in 4 consecutive cases. Arch Ophthalmol 2012; 130: 1327-1330
17 Reynolds SA, Shechtman D, Falco L. Complex juxtapapillary capillary hemangioma: a case report. Optometry 2008; 79: 512-517
18 Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015; 15: 55-64
19 Chelala E, Dirani A, Fadlallah A. Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature. Clin Ophthalmol 2013; 7: 2143-2146
20 Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999; 117: 371-378
21 Singh AD, Nouri M, Shields CL. et al. Treatment of retinal capillary hemangioma. Ophthalmology 2002; 109: 1799-1806
22 Lane CM, Turner G, Gregor ZJ. et al. Laser treatment of retinal angiomatosis. Eye (Lond) 1989; 3: 33-38
23 Shields JA. Response of retinal capillary hemangioma to cryotherapy. Arch Ophthalmol 1993; 111: 551
24 Sachdeva R, Dadgostar H, Kaiser PK. et al. Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol 2010; 88: e334-e340
25 Girmens JF, Erginay A, Massin P. et al. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol 2003; 136: 194-196
26 Seibel I, Cordini D, Hager A. et al. Long-term results after proton beam therapy for retinal papillary capillary hemangioma. Am J Ophthalmol 2014; 158: 381-386